Clonidine-specific antibodies as models for imidazole and α2-adrenergic receptor binding sites
- 1 December 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 6 (4) , S490-493
- https://doi.org/10.1097/00004872-198812040-00155
Abstract
Polyclonal antisera raised against para-aminoclonidine coupled to haemocyanin exhibit high affinity for para-aminoclonidine, clonidine and chloroethylclonidine (IC50 0.2 mmol/l). All of these compounds bind with high affinity to both imidazole and α2-adrenergic receptors. Compounds which are imidazole- or α2-specific do not cross-react with anti-para-aminoclonidine antibodies (IC50 >1 mmol/l). Anti-para-aminoclonidine also recognizes an endogenous clonidine-displacing substance in the brain. Thus, (a) binding to anti-para-aminoclonidine antibodies defines a subset of phenyl-imidazol(in)e ligands which bind to both imidazole and α2-adrenergic receptors, suggesting that anti-para-aminoclonidine recognition sites resemble a hybrid of the two receptor types; (b) antibodies to imidazole- or α2-specific agents may be useful as models for differentiating between these types; (c) since clonidine-displacing substance is recognized by anti-para-aminoclonidine antibodies, it may have phenyl and imidazole rings as parts of its chemical structure.Keywords
This publication has 0 references indexed in Scilit: